Drug intelligence / Profile preview

farrerol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Farrerol is a naturally occurring flavanone (a type of flavonoid) isolated from the dried leaves of *Rhododendron dauricum* L. (traditionally known as 'Man-shan-hong' in Chinese medicine). It has been historically used in China as an expectorant and antitussive agent for the treatment of chronic bronchitis and asthma. Beyond its traditional respiratory applications, farrerol exhibits a wide range of pharmacological properties, including anti-inflammatory, antioxidant, vasoactive, and antitumor activities. Mechanistically, farrerol acts as a direct activator of the deubiquitinase UCHL3, which promotes RAD51 deubiquitination and enhances homologous recombination (HR) DNA repair. It also directly inhibits protein tyrosine phosphatase non-receptor type 1 (PTPN1), alleviating insulin resistance and hepatic steatosis in metabolic models. In oncology, farrerol acts as an estrogen receptor antagonist, inhibiting the proliferation of estrogen receptor-positive breast cancer cells, and binds to VEGFA and VEGFR2 (KDR) to suppress colorectal cancer cell growth. Additionally, farrerol activates the Nrf2/ARE antioxidant pathway by targeting GSK-3β and Keap1, protecting against oxidative stress, ferroptosis, and tissue injury in models of diabetic cardiomyopathy, acute kidney injury, and acute lung injury.

Other names
(-)-farreroldujuansu杜鹃素法尔杜鹃素
02

Targets

ESR1 (ERα)VEGFA (Vascular endothelial growth factor A)GSK3 (Glycogen synthase kinase 3 beta)ESR2 (ERβ)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)VEGFR2 (Vascular endothelial growth factor receptor 2)PTPN1 (Protein tyrosine phosphatase 1B)

Beyond the preview

Go deeper on farrerol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on farrerol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call